Factor XIa Inhibitor Shows No Benefit After Acute Coronary Syndrome

122821



122821 (MedPage Today) — An investigational factor XIa inhibitor did not reduce the risk of recurrent cardiovascular (CV) events in patients with a recent acute coronary syndrome (ACS) event on top of antiplatelet therapy, although there was no increase…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *